Blaine Davis

RNAC

Blaine Davis serves as Chief Financial Officer at Cartesian Therapeutics, Inc. (RNAC). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$72.2K

Net Position

Net Seller

$72.2K

Companies Traded

RNAC

Active Period

Jan 2026

1 total trades

Most Recent

Sell RNAC

Jan 6, 2026 · $72.2K

Blaine Davis's Insider Trading at Cartesian Therapeutics, Inc. (RNAC)

Buys

0 · $0.00

Sells

1 · $72.2K

Total Shares Bought

Total Shares Sold

10,591

RNAC Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 6, 2026↗	Sell	10,591	$6.82	$72.2K	0

Related Insiders

Carsten Brunn

director, officer: President and CEO

RNACSell · Jan 6, 2026

Carsten Brunn

President and CEO

RNACSell · Jan 6, 2026

Milos Miljkovic

Chief Medical Officer

RNACSell · Jan 6, 2026

BARABE TIMOTHY C

Director

RNACBuy · Dec 4, 2025

SPRINGER TIMOTHY A

Director

RNACBuy · Apr 11, 2025

Explore More Insider Trading Data

RNAC Insider Trading Activity

View all insider trades at Cartesian Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity